Cognitive and Psychosocial Outcome After Mild Traumatic Brain Injury

Sponsor
Shanghai 6th People's Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT02161172
Collaborator
(none)
360
1
25
14.4

Study Details

Study Description

Brief Summary

Patients with traumatic brain injury are likely to present with cognitive, psychological, emotional and behavioral problems during different periods, all of which affect patients' life quality seriously. The aim of this study was to assess cognitive and psychosocial outcome in patients with mild traumatic brain injury, and to determine the risk factors associated with cognitive and psychological outcome. Mini-mental state examination (MMSE), activities of daily living scale (ADL), the Hospital Anxiety Depression Scale (HADS) and mental health symptom checklist (SCL-90) were used to assess the cognitive performance and psychological outcomes in 360 patients with mild traumatic brain injury. Chi-square, Fisher's exact tests and Logistic regression analysis were used to analyze the risk factors.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational [Patient Registry]
    Actual Enrollment :
    360 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Cross-Sectional
    Official Title:
    Cognitive, Functional, and Psychosocial Outcome After Mild Traumatic Brain Injury: a Cross-sectional Study at a Tertiary Care Trauma Center.
    Study Start Date :
    Apr 1, 2012
    Actual Primary Completion Date :
    Apr 1, 2014
    Actual Study Completion Date :
    May 1, 2014

    Arms and Interventions

    Arm Intervention/Treatment
    Mild traumatic brain injury

    Traumatic brain injury patients with Glasgow coma score (GCS) of 13-15.

    Outcome Measures

    Primary Outcome Measures

    1. Mini-Mental State Examination [6 months]

      MMSE includes seven factors, namely: the time orientation factor (5 points), place orientation (5 points), immediate memory (3 points), short-term memory (3 points), calculation capabilities (5 points), verbal expression, naming and repetition (4 points), speech reading and understanding (4 points), graphic depiction (1 points). The scales for the description of cognitive function impairment were grouped into three levels of education: illiteracy (17 points), primary school (20 points) and middle school (24 points). The one with score below average was considered with cognitive function impairment.

    Secondary Outcome Measures

    1. Activity of daily living scale [6 months]

      The scale is divided into two parts: physical self-care ability, instrumental activities of daily living. 1 point for each option means normal; If 2~4 points for one option, he or she probably had ability decline; If two or more parts ≥3 points or total score≥ 22 points (14 questions), he or she exhibited living ability decline clearly.

    Other Outcome Measures

    1. Hospital anxiety and depression Scale [6 months]

      The scale includes 14 items and each has 0-3 points. The score of the former seven items > 7, indicating depression symptom; the later seven items > 7, indicating anxiety symptom.

    2. Symptom Check-List 90 [6 months]

      This scale has been widely used to patients with neurosis, adjustment disorder and other slight mental psychological disorder. According to the national norm results, if the total score > 160, or the number of positive items > 43, or one factor score >2, we consider the positive screening.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 60 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • 18 ~ 60 years old

    • Education: primary school and above, who could understand the content of psychological test

    • History of brain trauma

    • No taking of antipsychotic or any other drugs affecting central nervous system before the test

    • Glasgow coma score (GCS) was 13-15

    Exclusion Criteria:
    • History of craniocerebral injury, brain disease, mental disease

    • With mental retardation

    • with other serious body diseases

    • History of drug and alcohol dependence

    • With color-blind or color weakness

    • Who had severe visual and auditory disorders after brain injury

    • Who failed or failed in completing the test effectively

    • With cognitive impairment caused by the damage of the unilateral frontal or bilateral lobes, or with language dysfunction caused by temporal lobe damage

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Shanghai Sixth People's Hospital Shanghai China 200233

    Sponsors and Collaborators

    • Shanghai 6th People's Hospital

    Investigators

    • Study Director: Heng-Li Tian, M.D., Ph.D., Shanghai 6th People's Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Hao Chen, Doctor, Shanghai 6th People's Hospital
    ClinicalTrials.gov Identifier:
    NCT02161172
    Other Study ID Numbers:
    • 658214
    First Posted:
    Jun 11, 2014
    Last Update Posted:
    Aug 11, 2020
    Last Verified:
    Aug 1, 2020
    Keywords provided by Hao Chen, Doctor, Shanghai 6th People's Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 11, 2020